AbCellera Biologics (ABCL) Shares Outstanding (Diluted Average) (2022 - 2026)
AbCellera Biologics (ABCL) reported Shares Outstanding (Diluted Average) of $303.1 million for Q1 2026, up 1.81% on a YoY basis from $297.7 million in Q1 2025, and up 1.41% quarter-over-quarter from $298.9 million in Q3 2025.
AbCellera Biologics (ABCL) Shares Outstanding (Diluted Average) (2022 - 2026) Analysis & Trends
AbCellera Biologics has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $303.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 810.00 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 92.44 Mn |
| 10 | AbCellera Biologics | 1.61 Bn | 1.51 Bn | - | 303.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 303.07 Mn |
| Sep 30, 2025 | 298.88 Mn |
| Jun 30, 2025 | 298.11 Mn |
| Mar 31, 2025 | 297.69 Mn |
| Sep 30, 2024 | 294.85 Mn |
| Jun 30, 2024 | 293.47 Mn |
| Mar 31, 2024 | 292.72 Mn |
| Sep 30, 2023 | 289.50 Mn |
| Jun 30, 2023 | 288.91 Mn |
| Mar 31, 2023 | 287.77 Mn |
| Sep 30, 2022 | 314.18 Mn |
| Jun 30, 2022 | 313.36 Mn |
| Mar 31, 2022 | 311.48 Mn |